Skip to main content

Oragenics Inc

OGEN
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0001174940

No open-market purchases or sales by Oragenics Inc insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $39.2K in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding Oragenics Inc changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of OGEN: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders13130
Shares52.5K61.4K+8.90K (+17.0%)
Value$173.5K$182.1K+$8.64K (+5.0%)

New holders (1)

Institutions that held Oragenics Inc at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to OGEN in Q3 2023
InstitutionSharesValue% of portfolio
Team Financial Group, LLC1$30.00%

Sold out (1)

Institutions that held Oragenics Inc at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of OGEN in Q3 2023
InstitutionShares, Q2 2023Value, Q2 2023
Northwestern Mutual Wealth Management Co35$116